Further evidence for risk of #MACE with cumulative GC use in RA In a national cohort of pts with RA: ⬆️cumulative GC exposure associated with ⬆️odds of MACE, regardless of baseline MACE risk Ab1719 #ACR24 @RheumNow https://t.co/RmxokfBXYX